The synthesis and anti-microbial activity of new spiro-β-lactams is reported. The design of the new molecules was based on the structural modulation of two previously identified lead spiro-penicillanates with dual activity against HIV and Plasmodium. The spiro-β-lactams synthesized were assayed for their in vitro activity against HIV-1, providing relevant structure-activity relationship information
报道了新型螺-β-内酰胺的合成和抗微生物活性。新分子的设计基于对先前鉴定出的两种对 HIV 和疟原虫具有双重活性的螺旋青霉酸铅的结构调节。分析了合成的螺-β-内酰胺类化合物对 HIV-1 的体外活性,提供了相关的构效关系信息。在测试的化合物中,两种螺环戊烯基-β-内酰胺被鉴定为对 HIV-1 具有显着的纳摩尔活性。此外,相同的分子显示出有希望的抗疟原虫活性,抑制疟原虫感染的肝脏和血液阶段。